WHO ICTRP trial
DNA Vaccine Coding for the Rhesus Prostate Specific Antigen (rhPSA) and…
EUCTR2006-001128-38-SE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2006-001128-38-SE |
|---|---|
| Public title | DNA Vaccine Coding for the Rhesus Prostate Specific Antigen (rhPSA) and Electroporation in Patients with Relapsed Prostate Cancer. A Phase I/II Study |
| Scientific title | DNA Vaccine Coding for the Rhesus Prostate Specific Antigen (rhPSA) and Electroporation in Patients with Relapsed Prostate Cancer. A Phase I/II Study |
| Primary sponsor | Uppsala University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | Patients with relapse of prostate cancer. |
| Interventions | Product Name: pVAXrcPSAv53l Product Code: pVAX/rhPSA Pharmaceutical Form: Solution for injection INN or Proposed INN: BICALUTAMIDE CAS Number: 90357065 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50… |
| Registration date | Jun 23, 2008 |
| Target size | 18 |
| Secondary IDs | pVAX/rhPSA -EP 2006 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: